AstraZeneca’s hopes of positioning its PD-L1 inhibitor Imfinzi as a post-surgery therapy for people with earlier-stage lung cancer have taken a knock, although it performed well in a bladder ...

Immunotherapy drug durvalumab, sold under the brand name Imfinzi, could help reduce the ... cancer and these are usually associated with old age and environmental factors such as smoking.” ...